BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22412273)

  • 1. Familial Guillain-Barré syndrome: First Indian report.
    Naik KR; Saroja AO; Patil BP
    Ann Indian Acad Neurol; 2012 Jan; 15(1):44-7. PubMed ID: 22412273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Guillain-Barré syndrome: A case report with literature review.
    Sarmah B; Upadhyaya N
    Neurol India; 2017; 65(4):804-807. PubMed ID: 28681756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiological criteria in the diagnosis of different clinical types of Guillain-Barre syndrome.
    Kalita J; Misra UK; Das M
    J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):289-93. PubMed ID: 17615164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU.
    Das S; Khan RK; Alam SM; Chowdhury NH; Das P
    Mymensingh Med J; 2018 Jul; 27(3):631-640. PubMed ID: 30141456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
    Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
    J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal conduction block at intermediate nerve segments in pure motor Guillain-Barré syndrome.
    Hong YH; Sung JJ; Oh MY; Moon HJ; Park KS; Lee KW
    J Peripher Nerv Syst; 2011 Mar; 16(1):37-46. PubMed ID: 21504501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unicenter, prospective study of Guillain-Barré syndrome in Spain.
    Sedano MJ; Orizaola P; Gallardo E; García A; Pelayo-Negro AL; Sánchez-Juan P; Infante J; Berciano J
    Acta Neurol Scand; 2019 Jun; 139(6):546-554. PubMed ID: 30929269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
    Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
    Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes.
    Uncini A; Manzoli C; Notturno F; Capasso M
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1157-63. PubMed ID: 20870864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cauda equina conduction time in Guillain-Barré syndrome.
    Matsumoto H; Hanajima R; Terao Y; Hashida H; Ugawa Y
    J Neurol Sci; 2015 Apr; 351(1-2):187-190. PubMed ID: 25770878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
    Puma A; Benoit J; Sacconi S; Uncini A
    BMC Neurol; 2018 Jul; 18(1):101. PubMed ID: 30031375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes.
    Uncini A; Yuki N
    Expert Rev Neurother; 2009 Jun; 9(6):869-84. PubMed ID: 19496690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
    Umapathi T; Li Z; Verma K; Yuki N
    Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Electrodiagnostic Features of Guillain-Barré Syndrome Among the Pediatric Population.
    Ashrafi MR; Mohammadalipoor A; Naeini AR; Amanat M; Tavasoli AR; Heidari M; Badv RS; Mohammadi M; Zamani GR; Rahimi-Dehgolan S; Rahimi R; Akbari MG
    J Child Neurol; 2020 Jun; 35(7):448-455. PubMed ID: 32156188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.
    Kalita J; Kumar M; Misra UK
    Pediatr Crit Care Med; 2019 Jul; 20(7):652-659. PubMed ID: 30985608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.
    Alanazy MH; Bakry SS; Alqahtani A; AlAkeel NS; Alazwary N; Osman AM; Mustafa RA; Al-Harbi TM; Abdulmana SO; Amper AC; Aldughaythir Y; Ali AS; Makkawi S; Maglan A; Alamoudi L; Alsulaiman F; Alabdali M; AlShareef AA; Abuzinadah AR; Bamaga AK
    BMC Neurol; 2021 Jul; 21(1):275. PubMed ID: 34253174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome: subtypes and predictors of outcome from India.
    Kalita J; Misra UK; Goyal G; Das M
    J Peripher Nerv Syst; 2014 Mar; 19(1):36-43. PubMed ID: 24456386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal degeneration in Guillain-Barré syndrome: a reappraisal.
    Berciano J
    J Neurol; 2021 Oct; 268(10):3728-3743. PubMed ID: 32607643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study.
    Sekiguchi Y; Uncini A; Yuki N; Misawa S; Notturno F; Nasu S; Kanai K; Noto Y; Fujimaki Y; Shibuya K; Ohmori S; Sato Y; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):23-8. PubMed ID: 22010183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barre Syndrome following Tuberculosis: A Rare Association.
    Lakhotia AN; Chouksey D; Jain R; Sodani AK
    J Neurosci Rural Pract; 2017; 8(2):296-299. PubMed ID: 28479815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.